Terms: = Kidney tumors AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
33 results:
1. Combination therapies in patients with favorable risk metastatic renal cell Carcinoma: A Systematic Review and Meta-Analysis.
Bolek H; Yekedüz E; Ürün Y
Cancer Treat Rev; 2024 Jan; 122():102667. PubMed ID: 38101099
[TBL] [Abstract] [Full Text] [Related]
2. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
[TBL] [Abstract] [Full Text] [Related]
3. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis.
Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; Hogan SL; Derebail VK
Nephrol Dial Transplant; 2023 Aug; 38(9):2009-2018. PubMed ID: 36549661
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Study of Three-Dimensional Laparoscopic Partial Nephrectomy for the treatment of Highly Complex Renal tumors with RENAL Nephrometry Scores of ≥10 Points.
Li M; Ren Y; Weng G
Biomed Res Int; 2020; 2020():5824209. PubMed ID: 33381559
[TBL] [Abstract] [Full Text] [Related]
6. [Deleted in lymphocytic leukemia 1 promoted proliferation and apoptosis of nephroblastoma cells through regulating miR-513a-5p and RANBP2 pathway].
Zhao JL; Zhao LL; Niu WZ; Ding XC; Zhang WL
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):849-855. PubMed ID: 33113626
[No Abstract] [Full Text] [Related]
7. Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.
Iribe Y; Furuya M; Shibata Y; Yasui M; Funahashi M; Ota J; Iwashita H; Nagashima Y; Hasumi H; Hayashi N; Makiyama K; Kondo K; Tanaka R; Yao M; Nakaigawa N
Fam Cancer; 2021 Jan; 20(1):75-80. PubMed ID: 32666341
[TBL] [Abstract] [Full Text] [Related]
8. Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial.
Tolaney SM; Wardley AM; Zambelli S; Hilton JF; Troso-Sandoval TA; Ricci F; Im SA; Kim SB; Johnston SR; Chan A; Goel S; Catron K; Chapman SC; Price GL; Yang Z; Gainford MC; André F
Lancet Oncol; 2020 Jun; 21(6):763-775. PubMed ID: 32353342
[TBL] [Abstract] [Full Text] [Related]
9. Robotic surgery does not affect upstaging of T1 renal masses.
Davaro F; Roberts J; May A; McFerrin C; Siddiqui S; Hamilton Z
J Robot Surg; 2020 Jun; 14(3):447-454. PubMed ID: 31456083
[TBL] [Abstract] [Full Text] [Related]
10. Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma.
Li P; Jahnke J; Pettit AR; Wong YN; Doshi JA
JAMA Netw Open; 2019 Jun; 2(6):e195806. PubMed ID: 31199450
[TBL] [Abstract] [Full Text] [Related]
11. Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies.
El Ali Z; Rottey S; Barthelemy P; Kotecki N; VAN Paemel R; Devrient D; Awada A; Gil T; Pannier D; Ryckewaert T; Waisse W; Clavier JB; Penel N; Vermassen T
Anticancer Res; 2019 Jun; 39(6):2993-3002. PubMed ID: 31177140
[TBL] [Abstract] [Full Text] [Related]
12. A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).
Ahn T; Roberts MJ; Abduljabar A; Joshi A; Perera M; Rhee H; Wood S; Vela I
Mol Imaging Biol; 2019 Oct; 21(5):799-807. PubMed ID: 30617728
[TBL] [Abstract] [Full Text] [Related]
13. Incidence of Diabetes Mellitus, Cardiovascular Diseases, and Cancer in Patients Undergoing Malabsorptive Surgery (Biliopancreatic Diversion and Biliointestinal Bypass) vs Medical treatment.
Pontiroli AE; Ceriani V; Sarro G; Micheletto G; Giovanelli A; Zakaria AS; Fanchini M; Osio C; Nosari I; Veronelli AM; Folli F;
Obes Surg; 2019 Mar; 29(3):935-942. PubMed ID: 30448983
[TBL] [Abstract] [Full Text] [Related]
14. Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
Gross-Goupil M; Kwon TG; Eto M; Ye D; Miyake H; Seo SI; Byun SS; Lee JL; Master V; Jin J; DeBenedetto R; Linke R; Casey M; Rosbrook B; Lechuga M; Valota O; Grande E; Quinn DI
Ann Oncol; 2018 Dec; 29(12):2371-2378. PubMed ID: 30346481
[TBL] [Abstract] [Full Text] [Related]
15. Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomy.
Berg S; Cole AP; Fletcher SA; Pucheril D; Nabi J; Lipsitz SR; Chang SL; Sun M; Noldus J; Harshman LC; Choueiri TK; Trinh QD
Urol Oncol; 2018 Sep; 36(9):400.e15-400.e22. PubMed ID: 30274640
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil.
Bergerot PG; Bergerot CD; Dizman N; Zequi S; Fay A; Dara Y; Maia MC; Cotta BN; Gonçalves EP; Formiga MN; Tariki MS; Clavijo DA; Choueiri TK; Lopes G; Pal SK
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 29281478
[TBL] [Abstract] [Full Text] [Related]
17. Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T
Marchioni M; Martel T; Bandini M; Pompe RS; Tian Z; Kapoor A; Cindolo L; Autorino R; Briganti A; Shariat SF; Schips L; Karakiewicz PI
World J Urol; 2017 Dec; 35(12):1899-1905. PubMed ID: 28849260
[TBL] [Abstract] [Full Text] [Related]
18. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract] [Full Text] [Related]
19. Screening for the Key lncRNA Targets Associated With Metastasis of Renal Clear Cell Carcinoma.
Liu H; Chen P; Jiang C; Han J; Zhao B; Ma Y; Mardan M
Medicine (Baltimore); 2016 Jan; 95(2):e2507. PubMed ID: 26765468
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of osseous metastasis in bone scintigraphy.
Davila D; Antoniou A; Chaudhry MA
Semin Nucl Med; 2015 Jan; 45(1):3-15. PubMed ID: 25475375
[TBL] [Abstract] [Full Text] [Related]
[Next]
